ScienceT2 · Outlet report
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
AstraZeneca, a leading U.K. pharmaceutical company, has announced plans to invest $50 billion in the United States. This move comes amidst the ongoing trade tensions between the…
3 updates1 source1 mention here
Aug 9, 2025
Latest: How Switzerland’s Tariff Drama Swung From Hope to Despair · Bloomberg